ATOS
ATOS
NASDAQ · Biotechnology

Atossa Therapeutics Inc

$1.96
+0.06 (+3.16%)
As of Sep 28, 10:31 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +329.6% upside
Low Target $5.85
Average Target $8.42
High Target $9.99
Current Price $1.96
Current
$1.96
Target
$8.42
$5.85 $8.42 avg $9.99
Scenario Analysis
Bear Case
$5.85
198.5%
Low target
Base Case
$8.42
+329.6%
Avg target
Bull Case
$9.99
+409.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$19.35
-89.9% from high
52-Week Low
$1.70
+15.3% from low
Target vs 52W High
$8.42
-56.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%